StemRegenin 1 attenuates the RANKL-induced osteoclastogenesis via inhibiting AhR-c-src-NF-κB/p-ERK MAPK-NFATc1 signaling pathway
Shengji Zhou(First Affiliated Hospital Zhejiang University), Fengchao Zhao(First Affiliated Hospital Zhejiang University)
Cited by 10
Related Papers
MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL‐Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway
|Oxidative Medicine and Cellular Longevity|2022|11
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
|Molecular Medicine|2022|11